Stereotaxis receives its first order for the next-generation robotic system, GenesisX. The company expects a full commercial ...

TD Cowen analyst Josh Jennings reiterated a Buy rating on Stereotaxis (STXS – Research Report) on January 27 and set a price target of $5.00.

GenesisX offers the benefits of robotic magnetic navigation while making the technology more accessible, Stereotaxis said.

Stereotaxis announced the first order for its GenesisX endovascular surgical robotics system utilizing robotic magnetic navigation.

ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally ...

Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval: St. Louis Tuesday, January 28, 2025, 16:00 Hrs [IST] Stereotaxis, a pioneer and global leader in surgica ...

Stereotaxis has won European CE mark approval for its MaGiC ablation catheter, a robotically navigated device for the ...

Stereotaxis' MAGiC catheter is a robotically-navigated magnetic ablation catheter designed to perform cardiac ablation procedures ... It builds upon existing benefits of robotic cardiac ablation with ...

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Stereotaxis (STXS – Research Report), with a price ...

14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Oulu ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Mapping and navigation apps are a ubiquitous element of smartphones and feature routinely in users’ lives. They have become essential for commuters, holiday-makers, taxi services and anyone hoping to ...